Integrating LC-MS and ligand binding assays to meet bioanalytical demands
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
Immunology expert, Dr. Anna Majowicz, shares how Spark Therapeutics research is helping tackle immunogenicity challenges in AAV-mediated gene therapy
The context-dependent role of the complement system in cancer has the potential to provide novel prognostic biomarkers to inform treatment decisions for cancer patients
Deepen your understanding of cell-based assays and the process of developing robust cell-based assays for GMP QC testing in modern drug development
Explore the importance of robust and reliable cell-based assays in the development of therapeutic bispecific antibodies in immuno-oncology
Experts from Xbrane Biopharma discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerated timelines
Explore the role of the complement system in infectious disease and discover the immunoassays that drive research, diagnostics, and therapeutic monitoring